In: BMC Cancer
Subjects: METILAÇÃO DE DNA NEOPLASIAS NEOPLASIAS PROSTÁTICAS METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORT, Rafael Sebastián; DUHAGON, María Ana; MATHÓ, Cecilia; et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, London, BioMed Central Ltd., v. 18, n. 1, p. 13 , 2018. Disponível em: < http://dx.doi.org/10.1186/s12885-018-4049-7 > DOI: 10.1186/s12885-018-4049-7.APA
Fort, R. S., Duhagon, M. A., Mathó, C., Geraldo, M. V., Ottati, M. C., Yamashita, A. S., et al. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18( 1), 13 . doi:10.1186/s12885-018-4049-7NLM
Fort RS, Duhagon MA, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .Available from: http://dx.doi.org/10.1186/s12885-018-4049-7Vancouver
Fort RS, Duhagon MA, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .Available from: http://dx.doi.org/10.1186/s12885-018-4049-7
